Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #58 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 18 Feb 2026 | Virgo Advisors Private Limited | Promoter group | Sell | 0 | ₹0 |
| 18 Feb 2026 | Aditi C Bhanot | Promoter | Buy | 0 | ₹0 |
| 3 Apr 2024 | Nomita Ramdas Chandavarkar | Promoter | Buy | 0 | ₹0 |
| 3 Apr 2024 | Meera Ramdas Chandavarkar | Promoter | Sell | 0 | ₹0 |
| 9 Jun 2022 | Melarkode Ganesan Parameswaran | Director | Buy | 0 | ₹0 |
| 12 Oct 2020 | LEO ADVISORS PRIVATE LIMITED | Promoter | Sell | 0 | ₹0 |
| 12 Oct 2020 | Meera Ramdas Chandavarkar | Promoter | Sell | 0 | ₹0 |
| 12 Oct 2020 | Aditi C Bhanot | Promoter | Sell | 0 | ₹0 |
| 12 Oct 2020 | Nomita Ramdas Chandavarkar | Director | Sell | 0 | ₹0 |
| 12 Oct 2020 | Nandan Mohan Chandavarkar | Director | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 12 Sep 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 1,075,388 | 631.4600 | NSE |
| 12 Sep 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 1,075,388 | 631.9200 | NSE |
| 12 Sep 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 1,075,388 | 631.4600 | NSE |
| 12 Sep 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 1,075,388 | 631.9200 | NSE |
| 28 Mar 2017 | MANGALA ASHOK CHANDAVARKAR | Block | Sell | 10,756,110 | 203.5500 | BSE |
| 28 Mar 2017 | ADITI FAMILY DISCRETIONARY TRUST | Block | Buy | 10,756,110 | 203.5500 | BSE |
| 28 Mar 2017 | ASHOK ANAND CHANDAVARKAR | Block | Sell | 16,134,016 | 203.5500 | BSE |
| 28 Mar 2017 | AMEYA FAMILY DISCRETIONARY TRUST | Block | Buy | 16,134,016 | 203.5500 | BSE |
| 28 Mar 2017 | ADITI FAMILY DISCRETIONARY TRUST | Bulk | Buy | 10,756,110 | 203.5500 | BSE |
| 28 Mar 2017 | MANGALA ASHOK CHANDAVARKAR | Bulk | Sell | 10,756,110 | 203.5500 | BSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 11 Feb 2026 | Interim Dividend - Rs 5 Per Share | 5.0000 | 11 Feb 2026 |
| 22 Nov 2024 | Interim Dividend - Rs 5 Per Share | 5.0000 | 22 Nov 2024 |
| 19 Mar 2020 | Interim Dividend - Rs 0.80 Per Share | 0.8000 | 21 Mar 2020 |
| 8 Aug 2017 | Annual General Meeting/Dividend - Rs 2.25 Per Share | 2.2500 | — |
| 17 Mar 2016 | Interim Dividend - Rs 2.25/- Per Share | 2.2500 | 19 Mar 2016 |
| 23 Sep 2015 | Annual General Meeting/ Dividend - Rs 2.25/- Per Share | 2.2500 | — |
| 28 Jul 2014 | Annual General Meeting/Dividend Rs 2.25/- Per Share | 2.2500 | — |
| 20 Aug 2013 | Annual General Meeting / Dividend - Rs 2.25/- Per Share | 2.2500 | — |
| 6 Aug 2012 | Annual General Meeting And Dividend Rs.2/- Per Share | 2.0000 | — |
| 13 Sep 2011 | Annual General Meeting And Dividend Rs.2/- Per Share | 2.0000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 19 Sep 2024 | OTHER | Annual General Meeting |
| 20 Sep 2023 | OTHER | Annual General Meeting |
| 25 Aug 2023 | BUYBACK | Buy Back |
| 13 Sep 2022 | OTHER | Annual General Meeting |
| 17 Feb 2022 | BUYBACK | Buy Back |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 5 Aug 2026 | Financial Results | Yes |
| 27 May 2026 | Financial Results | Yes |
| 5 Feb 2026 | Financial Results/Other business matters | Yes |
| 5 Feb 2026 | Financial Results/Dividend/Other business matters | Yes |
| 5 Nov 2025 | Financial Results/Other business matters | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.